AADI - Wall Street Estimates - Aadi Bioscience, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 2.9

0.694 %

$ 71.6 M

Market Cap

-1.27

P/E

Price Target Average

--43.97%

Revenue Forecast Estimate

13.30%

EBIT Estimate

25.55%

Net Income Estimate

26.08%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Aadi Bioscience, Inc.

Wall Street analysts predict an average 1-year price target for AADI of $1.62 , with forecasts ranging from a low of $1.5 to a high of $1.75 .

AADI Lowest Price Target Wall Street Target

1.5 USD -48.28%

AADI Average Price Target Wall Street Target

1.62 USD -43.97%

AADI Highest Price Target Wall Street Target

1.75 USD -39.66%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free